María Teresa
Hernández Sánchez
Investigadora en el periodo 2015-2021
Instituto de Investigación Biomédica de Salamanca
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Biomédica de Salamanca (8)
2021
-
Albuminuria pre-emptively identifies cardiac patients at risk of contrast-induced nephropathy
Journal of Clinical Medicine, Vol. 10, Núm. 21
-
The furosemide stress test and computational modeling identify renal damage sites associated with predisposition to acute kidney injury in rats
Translational Research, Vol. 231, pp. 76-91
2020
-
A meta-analysis of preclinical studies using antioxidants for the prevention of cisplatin nephrotoxicity: implications for clinical application
Critical Reviews in Toxicology, Vol. 50, Núm. 9, pp. 780-800
-
Designing new diagnostic systems for the early detection of tobacco-associated chronic renal damage in patients of a primary care centre in Salamanca, Spain: An observational, prospective study protocol
BMJ Open, Vol. 10, Núm. 3
-
Urinary transferrin pre-emptively identifies the risk of renal damage posed by subclinical tubular alterations
Biomedicine and Pharmacotherapy, Vol. 121
2019
-
Quercetin, a promising clinical candidate for the prevention of contrast-induced nephropathy
International Journal of Molecular Sciences, Vol. 20, Núm. 19
2017
2016
-
Exposición a pesticidas y esclerosis lateral amiotrófica: Cuantificación de la relación causa-efecto a través de la técnica de meta-análisis
Revista de Toxicologia, Vol. 33, Núm. 2, pp. 84-87